Q4 2025 Holdings
Filed 2026-02-13 | 68 holdings | $170.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| KLA Corporation(KLAC) | COM NEW | 482480100 | $26.6M | 21,883 | 15.6% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $16.3M | 302,842 | 9.6% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $8.6M | 1,592,938 | 5.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $8.3M | 260,000 | 4.8% |
| LAM Research Corporation(LRCX) | COM NEW | 512807306 | $6.9M | 40,329 | 4.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $6.7M | 269,000 | 3.9% |
| Structure Therapeutics Inc(GPCR) | SPONS ADR | 86366E106 | $6.3M | 90,000 | 3.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.8M | 55,000 | 2.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.6M | 171,000 | 2.7% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $4.2M | 107,500 | 2.5% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.2M | 441,019 | 2.5% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $4.0M | 705,955 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.9M | 27,190 | 2.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.6M | 253,000 | 2.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $3.3M | 462,700 | 1.9% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $3.2M | 195,000 | 1.9% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $3.1M | 80,600 | 1.8% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $2.8M | 315,400 | 1.7% |
| Immunome Inc(IMNM) | COM | 45257U108 | $2.8M | 130,000 | 1.6% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $2.3M | 67,200 | 1.4% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $2.2M | 44,000 | 1.3% |
| Quidelortho Corp | COM | 74838J101 | $2.1M | 72,548 | 1.2% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $2.0M | 152,100 | 1.2% |
| Biodesix Inc | COM | 09075X108 | $2.0M | 286,804 | 1.1% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $1.9M | 30,000 | 1.1% |
| Phreesia Inc(PHR) | COM | 71944F106 | $1.9M | 110,700 | 1.1% |
| EQT Corporation(EQT) | COM | 26884L109 | $1.9M | 34,619 | 1.1% |
| Harrow Health Inc(HROW) | COM | 415858109 | $1.7M | 34,000 | 1.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.6M | 43,000 | 1.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.5M | 281,730 | 0.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.5M | 3,000 | 0.9% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $1.4M | 62,000 | 0.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 50,000 | 0.8% |
| Nektar Therapeutics(NKTR) | COM | 640268306 | $1.3M | 31,000 | 0.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.2M | 16,000 | 0.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.2M | 150,000 | 0.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.1M | 6,061 | 0.6% |
| Masimo Corp(MASI) | COM | 574795100 | $1.1M | 8,280 | 0.6% |
| 10X Genomics Inc(TXG) | COM | 88025U109 | $962.3K | 59,000 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $941.2K | 21,000 | 0.6% |
| Pacific Biosciences of California Inc(PACB) | COM | 69404D108 | $935.0K | 500,000 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $920.6K | 57,000 | 0.5% |
| Freeport-Mcmoran CL(FCX) | CL-B | 35671D857 | $916.6K | 18,046 | 0.5% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $910.5K | 100,827 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $828.3K | 29,847 | 0.5% |
| Illumina Inc(ILMN) | COM | 452327109 | $787.0K | 6,000 | 0.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $736.8K | 30,789 | 0.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $679.7K | 10,100 | 0.4% |
| Biohaven LTD(BHVN) | COM | G11196105 | $670.2K | 59,365 | 0.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $664.5K | 8,688 | 0.4% |